Piramal Pharma Share Listing Date: A Comprehensive Guide

Piramal Pharma's share listing date is a significant milestone for investors and the company alike.

The company's shares were listed on the National Stock Exchange (NSE) on November 17, 2017, marking a major development in its history.

The listing on the NSE provided Piramal Pharma with access to a broader investor base and increased visibility in the market.

Piramal Pharma's listing on the NSE was a result of its successful demerger from Piramal Enterprises, a move that aimed to unlock the company's true potential.

Explore further: Class S Shares

Piramal Pharma Ltd. made its stock market debut on October 19, 2022, listing on the exchanges at ₹201.8 per share on the BSE and ₹200 per share on the NSE.

The company's shares opened at these prices but later fell by as much as 5% to close at ₹191.75 on BSE and ₹190 on NSE.

Piramal Pharma was demerged from Piramal Enterprises Ltd. in August, as part of a strategy to simplify the company's corporate structure.

A different take: Earnings per Common Share with Average and Diluted Shares

The demerger plan received a nod from the National Company Law Tribunal (NCLT) on August 12, and the company fixed September 1 as the record date for the demerger of Piramal Pharma.

Piramal Pharma includes Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC), and the India Consumer Healthcare business, which sells over-the-counter products.

The company offers a portfolio of differentiated pharma products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network over 100 countries.

Piramal Enterprises shares started trading ex-pharma business on Tuesday, 30 August, 2022.

The approval from the NCLT on the demerger of Piramal Pharma and the simplification of the corporate structure is a significant milestone, said Ajay Piramal, according to the company's press release.

Piramal Pharma received an approval from the Securities and Exchange Board of India (Sebi) to list shares on domestic stock exchanges BSE and NSE.

The company's shares will be listed at a fully paid face value of Rs 10 each.

For another approach, see: Piramal Finance Share Price

Piramal Pharma shares listed on stock exchanges on Wednesday, October 19, 2022, at ₹201.8 apiece on the BSE and started trading at ₹200 per share on the NSE.

The company received approval from the Securities and Exchange Board of India (Sebi) to list shares on domestic stock exchanges BSE and NSE last week.

Piramal Pharma Ltd (PPL) includes Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC), and the India Consumer Healthcare business, which sells over-the-counter products.

The demerger from PEL will firmly empower PPL to be future ready and enable it to independently pursue its growth strategies with sharper focus and identity.

The board of the company had approved the demerger of the Pharma business and the simplification of the corporate structure in October 2021.

Piramal Enterprises shares started trading ex-pharma business on Tuesday, 30 August, 2022, and the company fixed September 1, as the record date for the demerger of Piramal Pharma.

The approval from the NCLT on the demerger of our Pharma business and the simplification of the corporate structure is a significant milestone, according to Ajay Piramal.

Suggestion: Preferred Stock Shares

Piramal Pharma Ltd. listed its shares on the Indian stock exchanges on October 19, 2022.

The shares opened at ₹201.8 per share on the Bombay Stock Exchange (BSE) and at ₹200 per share on the National Stock Exchange (NSE).

Trading members of the exchange were informed that effective from October 19, 2022, the equity shares of Piramal Pharma Limited would be listed and admitted to dealings on the exchange.

The listing was a result of the demerger of Piramal Enterprises' Pharma business, which was approved by the National Company Law Tribunal (NCLT) in August 2022.

Piramal Enterprises shares started trading ex-pharma business on Tuesday, August 30, 2022, and the company fixed September 1 as the record date for the demerger of Piramal Pharma.

The shares of Piramal Pharma fell as low as 5% to close at ₹191.75 per share on BSE and at ₹190 per share on NSE.

Intriguing read: Day Trading Bot